Cargando…
EFFECT OF TOCILIZUMAB ON CARDIAC INJURY AND DYSFUNCTION IN COVID-19
Autores principales: | Zafar, Amna, Khambhati, Jay, Drobni, Zsofia, Gongora, Carlos, Horick, Nora K., Foulkes, Andrea, Serling-Boyd, Naomi J., Lin, Nina, Woolley, Ann E., Hartmann, Sarah, Gilman, Hannah K., Fernandes, Ana, Harvey, Liam, Sacks, Chana, Dougan, Michael, North, Crystal M., Kim, Arthur Y., Schoenfeld, Sara, Sen, Pritha, Meyerowitz, Eric, Januzzi, James L., Frigault, Matthew J., Mansour, Michael K., Stone, John H., Neilan, Tomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Cardiology Foundation. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091191/ https://www.ncbi.nlm.nih.gov/pubmed/34140106 http://dx.doi.org/10.1016/S0735-1097(21)04383-7 |
Ejemplares similares
-
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
por: Stone, John H., et al.
Publicado: (2020) -
Immunomodulation as Treatment for Severe Coronavirus Disease 2019: A Systematic Review of Current Modalities and Future Directions
por: Meyerowitz, Eric A, et al.
Publicado: (2020) -
Straightening up is required to nucleate new microtubules
por: Gardner, Melissa K.
Publicado: (2021) -
CTLA-4 and Autoimmunity: New Twists in the Tale
por: Walker, Lucy S.K.
Publicado: (2015) -
Spiking immunotherapy with a bacterial cocktail brings T cells back to the fight
por: Greathouse, K. Leigh, et al.
Publicado: (2021)